The change of retinal sensitivity with intravitreal injection of aflibercept for wet type of age-related macular degeneration.
Phase of Trial: Phase IV
Latest Information Update: 18 Dec 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 14 Dec 2017 Status changed from not yet recruiting to recruiting.
- 01 Dec 2015 Planned initiation date changed from 1 Feb 2015 to 1 Feb 2016, according to University Hospital Medical Information Network - Japan.
- 06 Jan 2015 New trial record